SYNBIOTICS
Synbiotics is an oncolytic virus drug research and development company. Based on synthetic biology technology and adenovirus platform, it develops better targeting, higher safety, and tumor-killing for different tumor indications. A new generation of oncolytic virus products with stronger capabilities. It was initiated and established by the team of Professor Xie Zhen, Department of Automation, Tsinghua University.
SYNBIOTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Address:
Haidian, Beijing, China
Country:
China
Website Url:
http://www.syngentech.com.cn
Status:
Active
Similar Organizations
InnoCan Pharma
InnoCan Pharma is a pharma tech company.that develops novel therapeutics platforms and products to improve quality of life.
Ixaltis
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.
TionLab Therapeutics
TionLab Therapeutics is a drug development company developing drug delivery systems for diabetes patients.
Official Site Inspections
http://www.syngentech.com.cn
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Synbiotics"
Synbiotics - Crunchbase Company Profile & Funding
Organization. Synbiotics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ... Also Known As Syngentech; Legal Name Beijing Hopson Gene …See details»
Our Science - SyngenTech
Synov is an oncolytic adenovirus therapy platform developed by SyngenTech for logical gene circuit-based regulation. Its first product, Synov1.1, is a gene therapy product targeting alpha-fetoprotein positive solid tumours. This innovative drug …See details»
Loading... | SyngenTech
Exploring the Power of Life. Enabling Biomedical Innovation with Synthetic Biological Technology. 探索生命的力量 ...See details»
Contact Us - SyngenTech
010-80767988 [email protected] Room 601, Building 1, No. 9 Medical Science Road, Life Science Park, Changping District, BeijingSee details»
Syngentech - Products, Competitors, Financials, Employees, …
Syngentech. Frequently Asked Questions (FAQ). When was Syngentech founded? Syngentech was founded in 2014. Where is Syngentech's headquarters? Syngentech's headquarters is …See details»
Beijing SyngenTech - PitchBook
Beijing SyngenTech General Information Description. Developer of new drugs intended to treat malignant tumors and genetic diseases. The company provides gene and cell drug development, scientific research, and clinical services …See details»
Beijing SyngenTech Co., Ltd.
Explore Beijing SyngenTech Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, and 6 literature, Disease Domain:Neoplasms, Technology Platform:circular RNA, Oncolytic virus, …See details»
Pipeline - SyngenTech
010-80767988 [email protected] Room 601, Building 1, No. 9 Medical Science Road, Life Science Park, Changping District, BeijingSee details»
Beijing Syngentech Co.,LTD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Beijing Syngentech Co.,LTD of Beijing, Beijing. Get the latest business insights from Dun & Bradstreet.See details»
Beijing SyngenTech Co., Ltd.
了解Beijing SyngenTech Co., Ltd. (北京合生基因科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验, 1篇新闻和6篇文献，疾病领域:肿瘤，技术平台:环状RNA，溶瘤病毒，药物:SynOV1.1腺病 …See details»
合生基因 - 搜狐
Aug 8, 2017 合生基因 (SyngenTech ®) 科研服务 (service.syngen.tech) 合生基因 ® 正面向全球生命科学研究者提供合成生物学科研服务，主要包括哺乳动物细胞基因编辑与调控服务。现已成功为包括清华大学、北京大学、中科院、复旦大学 …See details»
基本资料 - 北京合生基因科技有限公司 - 丁香通
2014年8月，国内第一家专注于合成生物学在科研和医药健康领域应用的生物技术公司——北京合生基因科技有限公司（Beijing Syngentech Co., Ltd.）于北京中关村生命科学园成立。 合生基 …See details»
Beijing Syngentech Co., Ltd.:Company Profile & Technical Research ...
Beijing Syngentech Co., Ltd. was founded in 2014. Beijing Syngentech Co., Ltd. has a total of 16 patents . Login to view all basic info. Data Snapshot. 16. Patent. 2. News. High Related …See details»
Syngentech | CipherBio
Explore Syngentech's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Beijing Syngentech Co., LTD. | Institution outputs | Nature Index
Date range: 1 December 2023 - 30 November 2024 No articles found. Beijing Syngentech Co., LTD. did not contribute to any primary research papers from Nature Index journals in the …See details»
祝贺合生基因入驻强生创新孵化器 JLABS @上海 - 搜狐
Jul 11, 2019 SyngenTech is a pioneer in the discovery and development of engineered live therapeutics to harness the immune system and fight cancers. SyngenTech’s proprietary …See details»
Research programme: chimeric antigen receptor macrophage
Chimeric antigen receptor macrophage (CAR-M) therapies are being developed by Beijing SyngenTech for the treatment of hepatocellular carcinoma (liver cancer). Research …See details»
Syn005 - Drug Targets, Indications, Patents - Synapse
Syn005, Initially developed by Beijing SyngenTech Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication: Solid ...See details»
北京合生基因科技有限公司 官方首页 - 生物在线
来自清华大学的一批合成生物学专家正在筹划组建国内第一家专注于合成生物学在科研和医药健康领域应用的生物技术公司，北京合生基因科技有限公司（以下简称合生基因）。See details»
mRNA therapeutic IP Q2 2024: New rights & CircRNAs
Sep 3, 2024 Q2 2024 Focus on a newcomer developing therapeutic circular RNA. Founded in 2014 in Beijing’s Zhongguancun Life Science Park, SYNGENTECH is a Chinese company …See details»